AZ Rides PACIFIC Wave To Be First In Early-Stage NSCLC
After Imfinzi's failure in the MYSTIC trial, AstraZeneca is very much back in the lung cancer game following the success of the PACIFIC study.
After Imfinzi's failure in the MYSTIC trial, AstraZeneca is very much back in the lung cancer game following the success of the PACIFIC study.